Research programme: companion diagnostics - Burning rock/AstraZeneca
Latest Information Update: 29 Apr 2024
At a glance
- Originator Burning Rock
- Developer AstraZeneca; Burning Rock
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Breast cancer; Prostate cancer